Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$905K Sell
6,790
-2,979
-30% -$337K ﹤0.01% 2354
2026
Q1
$1.09M Sell
9,769
-8,117
-45% -$961K ﹤0.01% 2104
2025
Q4
$2.41M Buy
+17,886
New +$1.95M ﹤0.01% 1776

Other funds holding ABVX

Walleye Trading's ABVX Position: Q2 2026 in Review

Walleye Trading reduced its Abivax (ABVX) stake by 30% in Q2 2026, selling an estimated $337K and leaving 6,790 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Walleye Trading first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41M in Q4 2025. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Walleye Trading held 6,790 shares of Abivax worth $905K as of Q2 2026.
  • Walleye Trading sold 2,979 Abivax shares in Q2 2026, an estimated $337K.
  • Abivax made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2354 holding.
  • Walleye Trading first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Walleye Trading's Abivax position peaked at $2.41M in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.